All individual numbers are from the SEC provided Financial Statement and Notes Data Sets. No guarantee is made for their accuracy. This report only shows the values that are common to a significant number of companies.
NEUMORA THERAPEUTICS, INC. Last Reported: 4/30/2024 Stock Symbol: NMRA

Business Address

490 ARSENAL WAY, SUITE 200

WATERTOWN , MA US 02472

Mailing Address

490 ARSENAL WAY, SUITE 200

WATERTOWN , MA US 02472
Phone Number: (857) 760-0900 / State Incorporated: DE / Fiscal Year End 12 /31

Balance Sheet

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021
Cash and Cash Equivalents $182,927,000.00 $374,038,000.00 $412,284,000.00 -- -- $240,943,000.00 $252,509,000.00 -- -- --
Accounts Receivable Net Current -- -- -- -- -- -- -- -- -- --
Inventory -- -- -- -- -- -- -- -- -- --
Prepaid Expenses and Other Current Assets $20,070,000.00 $24,297,000.00 $16,170,000.00 -- -- $16,021,000.00 -- -- -- --
Total Current Assets $442,785,000.00 $478,279,000.00 $525,735,000.00 -- -- $387,955,000.00 -- -- -- --
Property Plant and Equipement $1,635,000.00 $1,790,000.00 $1,934,000.00 -- -- $2,411,000.00 -- -- -- --
Intangible Assets Net -- -- -- -- -- -- -- -- -- --
Goodwill -- -- -- -- -- -- -- -- -- --
Other Assets -- -- -- -- -- $2,913,000.00 -- -- -- --
Total Assets $450,211,000.00 $496,195,000.00 $544,749,000.00 -- -- $426,234,000.00 -- -- -- --
Accounts Payable $1,492,000.00 $337,000.00 $2,229,000.00 -- -- $7,147,000.00 -- -- -- --
Accrued Liabilities $19,493,000.00 $21,257,000.00 $23,347,000.00 -- -- $11,536,000.00 -- -- -- --
Total Current Liabilities $25,669,000.00 $27,119,000.00 $32,056,000.00 -- -- $29,397,000.00 -- -- -- --
Long Term Debt -- -- -- -- -- -- -- -- -- --
Additional Paid-in Capital $1,181,829,000.00 $1,172,570,000.00 $1,107,693,000.00 -- -- $21,430,000.00 -- -- -- --
Accumulated Other Comprehensive Loss $-148,000.00 $-76,000.00 $-311,000.00 -- -- $-774,000.00 -- -- -- --
Accumulated Deficit $-757,155,000.00 $-703,434,000.00 $-594,704,000.00 -- -- $-467,509,000.00 -- -- -- --
Total Stockholders' Equity $424,542,000.00 $469,076,000.00 $512,693,000.00 $-513,541,000.00 $-477,920,000.00 $-446,850,000.00 $-422,001,000.00 $-394,708,000.00 $-366,017,000.00 $-325,221,000.00
Controlling Interest in Subsidiaries -- -- -- -- -- -- -- -- -- --
Total Liabilities and Equity $450,211,000.00 $496,195,000.00 $544,749,000.00 -- -- $426,234,000.00 -- -- -- --

Statement of Operations

Date 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022 6/30/2022 3/31/2022 12/31/2021
Total Revenues -- -- -- -- -- -- -- -- -- --
Cost of Revenues -- -- -- -- -- -- -- -- -- --
Gross Profit -- -- -- -- -- -- -- -- -- --
Research and Development $45,757,000.00 $142,719,000.00 $103,855,000.00 -- -- -- $22,549,000.00 -- -- --
Selling, General, and Administrative -- -- -- -- -- -- -- -- -- --
Total Operating Expenses $60,074,000.00 $252,098,000.00 $138,094,000.00 -- -- -- $30,602,000.00 -- -- --
Loss from Operations $-60,074,000.00 $-252,098,000.00 $-138,094,000.00 -- -- -- $-30,602,000.00 -- -- --
Loss Before Income Taxes -- $-235,657,000.00 -- -- -- -- -- -- -- --
Earnings Per Share Basic $-0.34 $-3.63 $-1.14 -- -- -- $-3.83 -- -- --
Weighted Average Shares Basic 157,943,000 65,021,000 35,428,000 -- -- -- 27,646,000 -- -- --
Earnings Per Share Diluted $-0.34 $-3.63 $-1.14 -- -- -- $-3.83 -- -- --
Weighted Average Shares Diluted 157,943,000 65,021,000 35,428,000 -- -- -- 26,841,000 -- -- --
Common Stock Shares Authorized -- 700,000,000 -- -- -- -- -- -- -- --
Common Stock Shares Outstanding -- 158,832,000 -- -- -- -- -- -- -- --
Common Stock Value $16,000.00 $16,000.00 $15,000.00 -- -- $3,000.00 -- -- -- --
Common Stock Par Or Stated Value Per Share -- $0.00 -- -- -- -- -- -- -- --
Payments Of Dividends Common Stock -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Authorized -- -- -- -- -- -- -- -- -- --
Preferred Stock Shares Outstanding -- -- -- -- -- -- -- -- -- --
Preferred Stock Value -- -- -- -- -- -- -- -- -- --
Preferred Stock Par Or Stated Value Per Share -- -- -- -- -- -- -- -- -- --
Share Price -- -- -- -- -- -- -- -- -- --
Copyright 2024 PursePoor.com